Scalene node biopsy in primary and recurrent invasive carcinoma of the cervix

Roger B. Lee, Geoffrey S. Weisbaum, Paul Heller, Robert C. Park

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Since June 1971, it has been the policy of the Walter Reed Army Medical Center's Gynecologic Oncology Service to biopsy the left scalene fat pad in two groups of patients presenting with carcinoma of the cervix: (1) primary cases with biopsy-proven metastatic involvement to high common iliac or paraaortic lymph nodes, and (2) all recurrent cases being considered for pelvic exenteration. From June 1971 through June 1979, 43 patients met these criteria for left scalene biopsy. Ten patients had primary disease and 33 had recurrent pelvic carcinoma. Three of ten patients, or 30%, with primary cervical carcinoma had positive left scalene biopsies. All 10 patients had clinically negative supraclavicular examinations. The 3 patients with positive scalene biopsy also had positive paraaortic lymph nodes. However, 4 patients with negative scalene biopsies also had positive aortic lymph nodes. Fourteen of the thirty-three patients with recurrent pelvic carcinoma had positive left scalene node biopsies. Eight of these fourteen were clinically positive, but the other 6 were clinically negative. Therefore, 6 of 25 patients, or 24%, with recurrent cervical carcinoma and clinically negative supraclavicular areas, had metastatic tumor present in the left scalene lymph nodes. In order that patients with widespread carcinoma of the cervix do not receive inappropriate treatment, we recommend scalene node biopsies for the following groups of patients: (1) all primary diagnosed patients with biopsy-proven positive paraaortic lymph nodes; (2) all patients with recurrent carcinoma who are being considered for a pelvic exenteration; and (3) all patients with primary or recurrent disease who have palpable supraclavicular masses.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalGynecologic Oncology
Volume11
Issue number2
DOIs
StatePublished - Jan 1 1981
Externally publishedYes

Fingerprint

Cervix Uteri
Carcinoma
Biopsy
Lymph Nodes
Pelvic Exenteration
Adipose Tissue

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Lee, Roger B. ; Weisbaum, Geoffrey S. ; Heller, Paul ; Park, Robert C. / Scalene node biopsy in primary and recurrent invasive carcinoma of the cervix. In: Gynecologic Oncology. 1981 ; Vol. 11, No. 2. pp. 200-206.
@article{e3a868015c714187969216a7593b3bb9,
title = "Scalene node biopsy in primary and recurrent invasive carcinoma of the cervix",
abstract = "Since June 1971, it has been the policy of the Walter Reed Army Medical Center's Gynecologic Oncology Service to biopsy the left scalene fat pad in two groups of patients presenting with carcinoma of the cervix: (1) primary cases with biopsy-proven metastatic involvement to high common iliac or paraaortic lymph nodes, and (2) all recurrent cases being considered for pelvic exenteration. From June 1971 through June 1979, 43 patients met these criteria for left scalene biopsy. Ten patients had primary disease and 33 had recurrent pelvic carcinoma. Three of ten patients, or 30{\%}, with primary cervical carcinoma had positive left scalene biopsies. All 10 patients had clinically negative supraclavicular examinations. The 3 patients with positive scalene biopsy also had positive paraaortic lymph nodes. However, 4 patients with negative scalene biopsies also had positive aortic lymph nodes. Fourteen of the thirty-three patients with recurrent pelvic carcinoma had positive left scalene node biopsies. Eight of these fourteen were clinically positive, but the other 6 were clinically negative. Therefore, 6 of 25 patients, or 24{\%}, with recurrent cervical carcinoma and clinically negative supraclavicular areas, had metastatic tumor present in the left scalene lymph nodes. In order that patients with widespread carcinoma of the cervix do not receive inappropriate treatment, we recommend scalene node biopsies for the following groups of patients: (1) all primary diagnosed patients with biopsy-proven positive paraaortic lymph nodes; (2) all patients with recurrent carcinoma who are being considered for a pelvic exenteration; and (3) all patients with primary or recurrent disease who have palpable supraclavicular masses.",
author = "Lee, {Roger B.} and Weisbaum, {Geoffrey S.} and Paul Heller and Park, {Robert C.}",
year = "1981",
month = "1",
day = "1",
doi = "10.1016/S0090-8258(81)80009-1",
language = "English (US)",
volume = "11",
pages = "200--206",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Scalene node biopsy in primary and recurrent invasive carcinoma of the cervix. / Lee, Roger B.; Weisbaum, Geoffrey S.; Heller, Paul; Park, Robert C.

In: Gynecologic Oncology, Vol. 11, No. 2, 01.01.1981, p. 200-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scalene node biopsy in primary and recurrent invasive carcinoma of the cervix

AU - Lee, Roger B.

AU - Weisbaum, Geoffrey S.

AU - Heller, Paul

AU - Park, Robert C.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - Since June 1971, it has been the policy of the Walter Reed Army Medical Center's Gynecologic Oncology Service to biopsy the left scalene fat pad in two groups of patients presenting with carcinoma of the cervix: (1) primary cases with biopsy-proven metastatic involvement to high common iliac or paraaortic lymph nodes, and (2) all recurrent cases being considered for pelvic exenteration. From June 1971 through June 1979, 43 patients met these criteria for left scalene biopsy. Ten patients had primary disease and 33 had recurrent pelvic carcinoma. Three of ten patients, or 30%, with primary cervical carcinoma had positive left scalene biopsies. All 10 patients had clinically negative supraclavicular examinations. The 3 patients with positive scalene biopsy also had positive paraaortic lymph nodes. However, 4 patients with negative scalene biopsies also had positive aortic lymph nodes. Fourteen of the thirty-three patients with recurrent pelvic carcinoma had positive left scalene node biopsies. Eight of these fourteen were clinically positive, but the other 6 were clinically negative. Therefore, 6 of 25 patients, or 24%, with recurrent cervical carcinoma and clinically negative supraclavicular areas, had metastatic tumor present in the left scalene lymph nodes. In order that patients with widespread carcinoma of the cervix do not receive inappropriate treatment, we recommend scalene node biopsies for the following groups of patients: (1) all primary diagnosed patients with biopsy-proven positive paraaortic lymph nodes; (2) all patients with recurrent carcinoma who are being considered for a pelvic exenteration; and (3) all patients with primary or recurrent disease who have palpable supraclavicular masses.

AB - Since June 1971, it has been the policy of the Walter Reed Army Medical Center's Gynecologic Oncology Service to biopsy the left scalene fat pad in two groups of patients presenting with carcinoma of the cervix: (1) primary cases with biopsy-proven metastatic involvement to high common iliac or paraaortic lymph nodes, and (2) all recurrent cases being considered for pelvic exenteration. From June 1971 through June 1979, 43 patients met these criteria for left scalene biopsy. Ten patients had primary disease and 33 had recurrent pelvic carcinoma. Three of ten patients, or 30%, with primary cervical carcinoma had positive left scalene biopsies. All 10 patients had clinically negative supraclavicular examinations. The 3 patients with positive scalene biopsy also had positive paraaortic lymph nodes. However, 4 patients with negative scalene biopsies also had positive aortic lymph nodes. Fourteen of the thirty-three patients with recurrent pelvic carcinoma had positive left scalene node biopsies. Eight of these fourteen were clinically positive, but the other 6 were clinically negative. Therefore, 6 of 25 patients, or 24%, with recurrent cervical carcinoma and clinically negative supraclavicular areas, had metastatic tumor present in the left scalene lymph nodes. In order that patients with widespread carcinoma of the cervix do not receive inappropriate treatment, we recommend scalene node biopsies for the following groups of patients: (1) all primary diagnosed patients with biopsy-proven positive paraaortic lymph nodes; (2) all patients with recurrent carcinoma who are being considered for a pelvic exenteration; and (3) all patients with primary or recurrent disease who have palpable supraclavicular masses.

UR - http://www.scopus.com/inward/record.url?scp=0019458328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019458328&partnerID=8YFLogxK

U2 - 10.1016/S0090-8258(81)80009-1

DO - 10.1016/S0090-8258(81)80009-1

M3 - Article

VL - 11

SP - 200

EP - 206

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -